APAC CIO Outlook
  • Home
  • CXO Insights
  • CIO Views
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • About us
Apac
  • Admired Tech

    Agile

    AI Healthcare

    Artificial Intelligence

    Augmented Reality

    Aviation

    Big Data

    Blockchain

    Cloud

    Cryptocurrency

    Cyber Security

    Digital Transformation

    Drone

    HPC

    Infrared

    Internet of Things

    Networking

    PropTech

    Remote Work

    Scheduling Software

    Simulation

    Startup

    Storage

    Wireless

  • Banking

    E-Commerce

    Education

    FinTech

    Food and Beverages

    Healthcare

    Insurance

    Legal

    Manufacturing

    Pharma and Life Science

    Retail

    Travel and Hospitality

  • Atlassian

    CISCO

    Microsoft

    Oracle

    Salesforce

    SAP

    ServiceNow

  • Business Intelligence

    CEM

    Cloud-based Planning

    Cognitive

    Compliance

    Contact Center

    Contact Tracing

    Contactless Payments

    Content Management System

    Corporate Finance

    CRM

    Custom Software Development

    Data Center

    Enterprise Architecture

    Enterprise Communications

    Enterprise Contract Management

    ERP

    Field Service

    HR Technology

    IT Service Management

    Managed Services

    Procurement

    Product Management

    RegTech

    Revenue Management

    Sales Tech

Menu
    • Pharma and Life Science
    • Augmented Reality
    • Agile
    • Cognitive
    • Cyber Security
    • Digital Transformation
    • Atlassian
    • E-Commerce
    • Managed Services
    • RegTech
    • CISCO
    • Blockchain
    • IoT
    • MORE
    #

    Apac CIO Outlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIO Outlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • Pharma and Life Science
    Editor's Pick (1 - 4 of 8)
    left
    The 4Ps of Digital Transformation in Pharmaceutical Industry

    Debraj Dasgupta, Operating Officer, Head of Strategy and Go-To-Market Planning Division, Nippon Boehringer Ingelheim

    Cloud Computing: Pharma Takes the Plunge

    Andy Newsom, SVP & CIO, CSL Behring

    Machine Learning & Artificial Intelligence in Healthcare Industry

    James Woo, CIO, The Farrer Park Company

    Connected Patients: Healthcare and the Internet of Things

    Geoff Feakes, Group CIO, Tunstall Healthcare Group

    Building a Quality-Focused IT Foundation for a Biopharmaceutical Enterprise

    Andy Newsom, SVP, CIO, CSL Behring

    Points of Focus for CIOs to Succeed in the Next Decade and Beyond

    Dr. Joseph Frassica, CMIO/CTO, Patient Care and Monitoring Solutions, Philips Healthcare

    Innovating Technology -Based Metadata Solutions for Improved Data Analysis

    Douglas Barta, CIO, PAREXEL International

    Real-Time Actionable Intelligence with a Solid Analytics Platform

    Rajeev Nair,

    right

    Asia Pharma Pursues Digital Health Shift

    By Ian Haydock, Editor in Chief, APAC, for Scrip and Pink Sheet, Pharma Intelligence, Informa

    Tweet
    content-image

    Ian Haydock, Editor in Chief, APAC, for Scrip and Pink Sheet, Pharma Intelligence, Informa

    As the pharma industry globally pursues technology and activities "beyond the pill" in its push towards digital health, some familiar but decidedly "un-pharma" names are cropping up in new collaborations.

    This includes in Japan, where gaming giant Bandai Namco is working with one major pharma group on new applications of its technology.

    Contrary to its high-tech image, the country has been relatively slow in its initial embrace of digital and online technologies. But given the burden that Japan’s rapidly aging population is placing on government-funded healthcare costs, the research-based pharma industry has been calling for a more preventative approach to health, and in turn, is now looking to play a broader role in well-being.

    Major corporate initiatives over the past couple of years in the Japan digital health space are focusing on treatment adherence and the capture of patient data related to general health and side-effects, with other moves made more recently to improve patient-physician interactions and efficacy of treatment.

    Chugai Pharmaceutical, for instance, has started to provide treatment support for selected oncology products under a collaboration with Tokyo-based venture Embrace. A dedicated mobile device application is being used with Embrace’s established private social network service MedicalCareStation, which allows patients to communicate to careproviders, their condition, and any side-effects that arise during treatment with Chugai’s non-small cell lung cancer drug Tecentriq (atezolizumab).

    Chugai has also set up with Tokyo-based Qlife (a Japanese healthcare advertising and marketing business) "Gan with." This is a dedicated information website on daily living issues facing cancer patients and their families and co-workers (Gan is the Japanese word for cancer), enabling them to share experiences.

    Otsuka Pharmaceutical has a global collaboration with the US venture Proteus Digital Health to develop “smart pills,” including a MyCite formulation of Otsuka’s blockbuster atypical antipsychotic Abilify (aripiprazole).

    The MyCite technology was approved in the US in November 2017, and the tablets are embedded during manufacture with an Ingestible Event Marker about the size of a sand grain and made of food ingredients, which activates on contact with stomach fluid. This is picked up by a wearable patch sensor, used with a dedicated app and website for healthcare providers.

    The IEM also logs activity levels and patient-reported rest and mood, which can be shared (upon consent) with doctors.

    Major corporate initiatives over the past couple of years in the Japan digital health space are focusing on treatment adherence and the capture of patient data

    Among other Japanese digital health players, Astellas Pharma has teamed up with Japan-based gaming company Bandai Namco Entertainment on the health prevention side, for the development of applications for smartphones and other mobile devices to encourage patients to take exercise.

    The aim is to take a proactive stand against metabolic syndrome, a recognized condition in Japan deriving from a combination of risk factors including weight, cholesterol levels, and diabetic state. The app encourages regular exercise with a "gamified" reward component and is used in conjunction with the MoffBand wearable bracelet.

    Astellas has been building up its digital health activities for several years, in 2016, launching DigiTx Partners, a San Francisco Bay Area-based digital health investment company.

    Meanwhile, digital health programs at Japan’s largest pharma company Takeda Pharmaceutical, continue to develop. The firm is exploring the application of digital technologies to improve the management of inflammatory bowel disease, where it has a significant strategic presence through Entyvio (vedolizumab) for Crohn's disease and ulcerative colitis.

    It launched a pilot project, iBData, in around 100 volunteers in 2016 in collaboration with Texas Digestive Disease Consultants and Vanderbilt University Medical Center in the US, to use wearable technology to track symptoms and potential disease-related lifestyle factors.

    Most of the company's other digital health initiatives are in the mental health and depression area, where it is working with Mindstrong Health to use "digital biomarkers," with a focus on optimizing therapy for treatment-resistant depression and schizophrenia. A "digital phenotyping" system continuously measures brain function from passively collected smartphone data.

    Takeda is also working with Danish pharma firm Lundbeck (with which it has partnered several depression products) and Advocate Health Care in the US to use a mobile app, Advocate Pathway, to capture depression treatment and related changes in mood and side-effects, and to share these with care providers to improve engagement.

    A program in the UK partners with Cognition Kit to use the Apple Watch for cognitive and mood assessment and data collection and results so far have shown generally high compliance with the system.

    Along the same lines, Takeda is using private US company Koneksa's technology to capture patients' health data during clinical trials.

    In the dementia area, Eisai has been running since 2016 “Hikari One Team SP”, a cloud-based, subscription digital health initiative to link Alzheimer’s patients and their carers, by sharing well-being data and therapy plans.

    The company markets Aricept (donepezil) for Alzheimer’s and is developing other therapies in the disease, and the project fits with Japan’s broader goal of better-integrating home treatment into the health system.

    (Ian Haydock (ian.haydock@informa.com) is the Tokyo-based editor-in-chief, Asia Pacific, for Informa’s Pharma Insights products, which include Scrip, Pink Sheet and In Vivo.)

    For further information on Scrip and the Pink Sheet or to register for a free, 7-day trial, please see:

    https://pharmaintelligence.informa.com/products-and-services/news-and-insights/pink-sheet

    https://pharmaintelligence.informa.com/products-and-services/news-and-insights/scrip

    tag

    Pharmaceutical

    Entertainment

    Sensor

    Weekly Brief

    loading
    Top 10 Pharma and Life Science Technology Companies - 2020

    Featured Vendors

    Cbig Consulting

    Cameron Price, Managing Partner, Asia-Pacific Region

    Bluesoftware

    Stephen Kaufman, Chief Product Officer

    ON THE DECK

    Pharma and Life Science 2020

    Top Vendors

    Pharma and Life Science 2019

    Top Vendors

    Previous Next

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

     A Picture of Health: Why we need a unified approach to Covid-safe air travel

    A Picture of Health: Why we need a unified approach to Covid-safe air travel

    Brandon Balcom, Snr. Director, Innovation Business Development, CWT
    The Battle Of David & Goliath Within The Retail Landscape

    The Battle Of David & Goliath Within The Retail Landscape

    Vlad Yakubson, Head Of Retail, Yd
    Thinking Out-Of-The-Box To Launch Business Beyond Borders

    Thinking Out-Of-The-Box To Launch Business Beyond Borders

    Bill Bass, Chief Marketing Officer And Kara Lawson, Senior Director Ecommerce, Fullbeauty Brands
    Driving Transformative, Datadriven Thinking

    Driving Transformative, Datadriven Thinking

    Shubham Mehrish, Vice President, Mars
    Retail is Detail They Say

    Retail is Detail They Say

    STUART FREER, CHIEF DIGITAL OFFICER, MECCA BRANDS
    Blockchain: The answer to solve the perennial issues in the Telecom Industry

    Blockchain: The answer to solve the perennial issues in the Telecom Industry

    Neeti Virmani, Venture Partner, Loyal VC
    Self Service: An important slice of the digital transformation pie

    Self Service: An important slice of the digital transformation pie

    Christopher Douglas, Director Member Services Pacific, Accor Plus
    Leveraging POS Systems to Enhance Customer Experiences in Retail

    Leveraging POS Systems to Enhance Customer Experiences in Retail

    Bernie Winter, Director of Point-of-Sale Systems, and Mike Metz, Vice President of Information Technology, Tops Friendly Markets
    Loading...

    Copyright © 2021 APAC CIOoutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    |  Sitemap |  Subscribe

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://pharma.apacciooutlook.com/cxoinsights/asia-pharma-pursues-digital-health-shift--nwid-7144.html